Compare Moody's Corporation (MCO) vs Twist Bioscience Corp (TWST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Moody's Corporation vs Twist Bioscience Corp — how do they compare? Moody's Corporation trades at $476.73 (market cap $82.52B), while Twist Bioscience Corp trades at $124 (market cap $7.72B). The key difference: Moody's Corporation is far larger — about 10.7× Twist Bioscience Corp's market cap, and Moody's Corporation pays a 0.86% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals.
| MCO | TWST | |
|---|---|---|
Market Cap | $82.52B | $7.72B |
Sector | Financials | Health |
52-Week High | $539.61 | $124.88 |
52-Week Low | $412.23 | $24.16 |
Enterprise Value | $88.54B | $7.65B |
Dividend Yield | 0.86% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Moody's Corporation
Moody's, along with S&P Ratings, is a leading provider of credit ratings on fixed income securities. Moody's ratings segment, known as Moody's Investors Service or MIS, includes corporates, structured finance, financial institutions, and public finance ratings. MIS represents a majority of the firm's revenue and profits. Moody's other segment is Moody's Analytics and consists of Research, Data, and Analytics or RD&A and Enterprise Risk Solutions or ERS. RD&A's products include credit research, quantitative credit scores, economic research, business intelligence, know your customer (KYC) tools, commercial real estate data and analytical tools, and training services. ERS includes risk management software solutions to financial institutions.
Read more on MCO →About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →
